收藏本站
我的資料
我的訂單
  購物車 (0)  
親,您的購物車空空的喲~
去購物車結(jié)算
   
查看手機網(wǎng)站
其他賬號登錄: 注冊 登錄
150-21460884
產(chǎn)品分類
CDI (1,1′-Carbonyldiimidazole) 
CDI (1,1′-Carbonyldiimidazole)
收藏
|
|
英文名稱 : CDI (1,1′-Carbonyldiimidazole)
貨號 : EY-01Y19126
CAS : 530-62-1
含量 : >98.00%
規(guī)格 : 100g
品牌 : 上海一研
價格 :
0.00
購買數(shù)量:
加入購物車  立即購買
產(chǎn)品保證
正品保證
快速發(fā)貨
產(chǎn)品詳情
產(chǎn)品評論(0)
銷售記錄(0)

產(chǎn)品屬性:


產(chǎn)品名稱

CDI (1,1′-Carbonyldiimidazole)

規(guī)格

100g

貨號

EY-01Y19126

Cas No.: 530-62-1

化學(xué)名: di(imidazol-1-yl)methanone

分子式: C7H6N4O
GA10168.png
分子量: 162.15

溶解度: Soluble in water or 1% acetic acid

儲存條件: Desiccate at -20°C
General tips:For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.

Shipping Condition:Evaluation sample solution : ship with blue ice

All other available size: ship with RT , or blue ice upon request

產(chǎn)品描述:


IC50: Not available.The common method of peptide synthesis is not feasible for industry use due to its poor yields. CDI, a new peptide forming reagent, is applied recently as a more direct agent for the formation of acyl-imidazoles. [1] In vitro: CDI can be prepared straightforwardly by the reaction of phosgene with four equivalents of imidazole under anhydrous conditions. It served as a convenient reagent for peptide synthesis since its side products, carbon dioxide and imidazole, were safe. Moreover, the carbon dioxide evolution was suggested to provide driving force for the peptide synthesis. A typical peptide-formation reaction was started by dissolving 0.010 mole acylamino acid in 10 ml tetrahydrofuran (THF), and after this, the evolution of carbon dioxide could be immediately observed. An hour later, the required amino acid or peptide ester was added with an amount of 0.010 molar. The reaction would be last for 15 min, but longer standing is probably beneficial. The formed peptide was then purified by wiping off the solvent under vacuum followed by washing the residue with acid, saturated bicarbonate and finally water.[1]In vivo: So far, no in vivo data has been reported.Clinical trial: So far, no clinical trial has been conducted.
特別提醒公司產(chǎn)品僅供科研使用


買家數(shù)量成交時間
正品保障

確保所有產(chǎn)品都是原裝正品

優(yōu)質(zhì)服務(wù)

優(yōu)質(zhì)服務(wù),售后無憂

安全包裝

統(tǒng)一包裝,保障產(chǎn)品安全運輸

正規(guī)發(fā)票

機打發(fā)票,附箱送達

    配送方式            新手入門           售后服務(wù)           幫助中心           支付方式           關(guān)于我們
      包裝說明                會員服務(wù)                退款說明                服務(wù)協(xié)議               預(yù)付賬戶               聯(lián)系一研
      商品驗收                積分規(guī)則               退換款地址            投訴建議                發(fā)票制度
      配送查詢                購物流程                退換款流程            聯(lián)系客服               付款周期
      配送說明                會員體系                退換款原則            找回密碼               付款方式
手機掃一掃
訪問手機網(wǎng)站
封开县| 白河县| 开远市| 西吉县| 色达县| 荥阳市| 高尔夫| 南丰县| 宜宾县| 永靖县| 抚顺县| 分宜县| 巩义市| 宜兴市| 乐平市| 开封市| 洪泽县| 泰宁县| 双鸭山市| 阿勒泰市| 高淳县| 清苑县| 柳州市| 宁都县| 吐鲁番市| 阿合奇县| 新兴县| 朝阳区| 新余市| 华阴市| 香港| 克什克腾旗| 卢氏县| 县级市| 红桥区| 吐鲁番市| 娱乐| 太仆寺旗| 大港区| 清水县| 靖边县|